Tetramethylpyrazine reverses anxiety-like behaviors in a rat model of post-traumatic stress disorder.
10.4196/kjpp.2018.22.5.525
- Author:
Bombi LEE
1
;
Insop SHIM
;
Hyejung LEE
;
Dae Hyun HAHM
Author Information
1. Acupuncture and Meridian Science Research Center, Kyung Hee University, Seoul 02447, Korea. bombi@khu.ac.kr
- Publication Type:Original Article
- Keywords:
Anxiety;
Post-traumatic stress disorder;
Serotonin;
Single prolonged stress;
Tetramethylpyrazine
- MeSH:
Animals;
Anxiety;
Arm;
Freezing;
Grooming;
Hippocampus;
Humans;
Models, Animal*;
Prefrontal Cortex;
Rats*;
RNA, Messenger;
Serotonin;
Stress Disorders, Post-Traumatic*;
Thymidine Monophosphate;
Tryptophan
- From:The Korean Journal of Physiology and Pharmacology
2018;22(5):525-538
- CountryRepublic of Korea
- Language:English
-
Abstract:
Post-traumatic stress disorder (PTSD) is a trauma-induced psychiatric disorder characterized by impaired fear extermination, hyperarousal, and anxiety that may involve the release of monoamines in the fear circuit. The reported pharmacological properties of tetramethylpyrazine (TMP) include anti-cancer, anti-diabetic, anti-atherosclerotic, and neuropsychiatric activities. However, the anxiolytic-like effects of TMP and its mechanism of action in PTSD are unclear. This study measured several anxiety-related behavioral responses to examine the effects of TMP on symptoms of anxiety in rats after single prolonged stress (SPS) exposure by reversing the serotonin (5-HT) and hypothalamic-pituitary-adrenal (HPA) axis dysfunction. Rats were given TMP (10, 20, or 40 mg/kg, i.p.) for 14 days after SPS exposure. Administration of TMP significantly reduced grooming behavior, increased the time spent and number of visits to the open arm in the elevated plus maze test, and significantly increased the number of central zone crossings in the open field test. TMP administration significantly reduced the freezing response to contextual fear conditioning and significantly restored the neurochemical abnormalities and the SPS-induced decrease in 5-HT tissue levels in the prefrontal cortex and hippocampus. The increased 5-HT concentration during TMP treatment might be partially attribute to the tryptophan and 5-hydroxyindoleacetic acid mRNA level expression in the hippocampus of rats with PTSD. These findings support a role for reducing the altered serotonergic transmission in rats with PTSD. TMP simultaneously attenuated the HPA axis dysfunction. Therefore, TMP may be useful for developing an agent for treating psychiatric disorders, such those observed in patients with PTSD.
